Status:
UNKNOWN
Computed Tomography Perfusion Colorectal Cancer With Tumor Grade
Lead Sponsor:
Assiut University
Conditions:
Colo-rectal Cancer
Eligibility:
All Genders
Brief Summary
Colorectal cancer is the third most commonly diagnosed cancer in the world. The 5-years survival rate depends on the tumor stage and grade at patient presentation. Individual treatment strategy based ...
Detailed Description
Diagnosis of cancer colon is usually based on colonoscopy which provides direct visualization of the lesions and allows for biopsies. However the pre-operative specimens from endoscopic biopsies somet...
Eligibility Criteria
Inclusion
- Any patient with primary colorectal mass
Exclusion
- Colorectal mass pathologically proved to be benign Female patient at child bearing period with suspected pregnancy Raised renal chemistry Hypersensitivity to contrast.
Key Trial Info
Start Date :
March 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 10 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03448302
Start Date
March 10 2018
End Date
July 10 2019
Last Update
February 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine
Asyut, Egypt